FDA Inspection 1308840 — Piramal Pharma Limited

Piramal Pharma Limited — FEI 3003803288

The FDA completed an inspection of Piramal Pharma Limited on February 13, 2026 in Kohir Mandal. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 13, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kohir Mandal (India)